Kyowa Hakko Kirin Company Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Kyowa Hakko Kirin Company Limited with three other
companies in this sector in Japan:
Taisho Pharmaceutical Holdings Co Ltd
sales of 290.50 billion Japanese Yen [US$2.58 billion]
of which 61%
Mitsubishi Tanabe Pharma Corp
(415.12 billion Japanese Yen [US$3.69 billion]
Shionogi & Co Ltd
(273.99 billion Japanese Yen [US$2.43 billion]
of which 100%
During the year ended December of 2015, sales at
Kyowa Hakko Kirin Company Limited were ¥364.32 billion (US$3.24 billion).
increase of 9.3%
versus 2014, when the company's sales were ¥333.45 billion.
Sales of Pharmaceutical Business saw an increase
10.5% in 2015, from
¥251.88 billion to ¥278.40 billion.